NO309925B1 - FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor - Google Patents

FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor Download PDF

Info

Publication number
NO309925B1
NO309925B1 NO953192A NO953192A NO309925B1 NO 309925 B1 NO309925 B1 NO 309925B1 NO 953192 A NO953192 A NO 953192A NO 953192 A NO953192 A NO 953192A NO 309925 B1 NO309925 B1 NO 309925B1
Authority
NO
Norway
Prior art keywords
weight
amount
formulation
formulation comprises
total formulation
Prior art date
Application number
NO953192A
Other languages
English (en)
Norwegian (no)
Other versions
NO953192L (no
NO953192D0 (no
Inventor
Flavia Arce Mendizabal
Original Assignee
Lilly Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Sa filed Critical Lilly Sa
Publication of NO953192D0 publication Critical patent/NO953192D0/no
Publication of NO953192L publication Critical patent/NO953192L/no
Publication of NO309925B1 publication Critical patent/NO309925B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO953192A 1994-12-13 1995-08-14 FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor NO309925B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09402530A ES2079327B1 (es) 1994-12-13 1994-12-13 Formulaciones farmaceuticas de cefaclor.

Publications (3)

Publication Number Publication Date
NO953192D0 NO953192D0 (no) 1995-08-14
NO953192L NO953192L (no) 1996-06-14
NO309925B1 true NO309925B1 (no) 2001-04-23

Family

ID=8288235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953192A NO309925B1 (no) 1994-12-13 1995-08-14 FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor

Country Status (31)

Country Link
US (1) US5861141A (fr)
EP (3) EP1086689A3 (fr)
JP (1) JPH08208484A (fr)
KR (1) KR100350565B1 (fr)
CN (1) CN1136852C (fr)
AT (1) ATE201984T1 (fr)
AU (1) AU702585B2 (fr)
BR (1) BR9504573A (fr)
CA (1) CA2158511A1 (fr)
CO (1) CO4410176A1 (fr)
CZ (1) CZ287248B6 (fr)
DE (2) DE69521275T2 (fr)
DK (1) DK0716852T3 (fr)
ES (2) ES2079327B1 (fr)
FI (1) FI953887A7 (fr)
GR (2) GR960300062T1 (fr)
HU (1) HUT73792A (fr)
IL (1) IL114642A (fr)
MY (1) MY114687A (fr)
NO (1) NO309925B1 (fr)
NZ (1) NZ272611A (fr)
PE (1) PE5196A1 (fr)
PL (1) PL181437B1 (fr)
PT (1) PT716852E (fr)
RU (1) RU2150276C1 (fr)
SI (1) SI0716852T1 (fr)
TR (1) TR199501165A1 (fr)
TW (1) TW492875B (fr)
UA (1) UA34479C2 (fr)
YU (1) YU60795A (fr)
ZA (1) ZA956411B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE216887T1 (de) * 1996-02-29 2002-05-15 Fujisawa Pharmaceutical Co Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
WO1999018965A1 (fr) * 1997-10-10 1999-04-22 Yamanouchi Europe B.V. Compositions orales contenant un antibiotique de type cephalosporine
CA2352430C (fr) * 1998-12-01 2008-11-18 Novo Nordisk A/S Nouvelle composition pharmaceutique et procede de preparation
DE10005017A1 (de) * 2000-02-04 2001-08-09 Cognis Deutschland Gmbh Duftstofftabletten
JP2004531537A (ja) * 2001-05-01 2004-10-14 ファイザー・プロダクツ・インク 一様な薬剤分布と効力を有する低用量製薬組成物の製造方法
US7151432B2 (en) 2001-09-19 2006-12-19 Immersion Corporation Circuit and method for a switch matrix and switch sensing
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
EP1732605B1 (fr) * 2004-03-29 2019-05-08 Wyeth LLC Complements nutritionnels mineraux multivitamines
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
US9198862B2 (en) 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
EP1923074A4 (fr) 2005-08-10 2011-09-14 Shionogi & Co Comprimé pouvant être désintégré par voie orale
CN102579455B (zh) * 2012-03-19 2014-02-19 迪沙药业集团有限公司 一种稳定的头孢克洛咀嚼组合物
WO2017045742A1 (fr) * 2015-09-14 2017-03-23 Merck Patent Gmbh Formulation à libération retardée contrôlée du principe actif
CN113750066B (zh) * 2021-10-12 2022-12-02 上海金城素智药业有限公司 一种具有临床优势的头孢克洛制剂及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
YU36970B (en) 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
US3925372A (en) 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
GB2066662B (en) * 1979-12-21 1984-02-15 Glaxo Group Ltd Cephalexin powder compositions containing silicon dioxide
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
EP0181966A1 (fr) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Comprimés dispersibles enrobés par compression
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
EP0319074B1 (fr) * 1987-11-30 1992-01-29 Brocades Pharma B.V. Composition pharmaceutique et procédé de sa préparation
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
FR2669221B1 (fr) * 1990-11-15 1993-01-15 Rhone Poulenc Sante Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
ES2066092T3 (es) * 1990-11-29 1995-03-01 Wei Ming Pharmaceutical Mfg Co Coadyuvante para la formacion directa de comprimidos.
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico
CZ283428B6 (cs) * 1992-04-30 1998-04-15 Schering Corporation Stabilní hydratovaný suchý práškový cefalosporin vhodný pro orální aplikaci ve formě suspenze
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5616344A (en) * 1994-06-14 1997-04-01 Fuisz Technologies Ltd. Apparatus and process for strengthening low density compression dosage units and product therefrom
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
AU2509495A (en) 1996-06-20
HU9502160D0 (en) 1995-09-28
US5861141A (en) 1999-01-19
NZ272611A (en) 1997-08-22
JPH08208484A (ja) 1996-08-13
ES2091738T3 (es) 2001-08-16
PL181437B1 (pl) 2001-07-31
NO953192L (no) 1996-06-14
TW492875B (en) 2002-07-01
IL114642A0 (en) 1995-11-27
CN1136852C (zh) 2004-02-04
PL309863A1 (en) 1996-06-24
AU702585B2 (en) 1999-02-25
EP1086689A2 (fr) 2001-03-28
FI953887A0 (fi) 1995-08-17
EP0716852B1 (fr) 2001-06-13
CO4410176A1 (es) 1997-01-09
EP1086689A3 (fr) 2001-07-11
TR199501165A1 (tr) 1996-10-21
EP1086690A3 (fr) 2001-07-11
ZA956411B (en) 1996-03-11
CZ199895A3 (en) 1996-07-17
BR9504573A (pt) 1997-02-25
YU60795A (sh) 1998-07-10
UA34479C2 (uk) 2001-03-15
DE69521275T2 (de) 2001-10-31
DK0716852T3 (da) 2001-09-03
CA2158511A1 (fr) 1996-06-14
HUT73792A (en) 1996-09-30
DE716852T1 (de) 1997-04-03
ES2079327B1 (es) 1996-08-01
NO953192D0 (no) 1995-08-14
CZ287248B6 (en) 2000-10-11
EP1086690A2 (fr) 2001-03-28
SI0716852T1 (en) 2001-12-31
FI953887L (fi) 1996-06-14
RU2150276C1 (ru) 2000-06-10
MY114687A (en) 2002-12-31
ES2079327A1 (es) 1996-01-01
ES2091738T1 (es) 1996-11-16
GR960300062T1 (en) 1996-11-30
KR100350565B1 (ko) 2003-02-05
FI953887A7 (fi) 1996-06-14
GR3036503T3 (en) 2001-11-30
ATE201984T1 (de) 2001-06-15
IL114642A (en) 1999-07-14
HK1012574A1 (en) 1999-08-06
EP0716852A1 (fr) 1996-06-19
DE69521275D1 (de) 2001-07-19
PE5196A1 (es) 1996-03-26
CN1130506A (zh) 1996-09-11
KR960021026A (ko) 1996-07-18
PT716852E (pt) 2001-09-28

Similar Documents

Publication Publication Date Title
US5747068A (en) Flouxetine pharmaceutical formulations
US5211958A (en) Pharmaceutical composition and process for its preparation
JP3180350B2 (ja) β―ラクタム系抗生物質含有錠剤およびその製造法
CA2301185C (fr) Preparation pharmaceutique comprenant du clodronate en tant que principe actif et de la cellulose microcristalline silicifiee en tant qu'excipient
NO309925B1 (no) FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor
NO174996B (no) Fremgangsmåte for fremstilling av et granulat og en tablett inneholdende granulatet
JPH02211A (ja) 製薬学的組成物及びその製法
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
HK1012574B (en) Pharmaceutical formulations of cefaclor
HK1012573B (en) Fluoxetine pharmaceutical formulations
CA2154413A1 (fr) Compositions pharmaceutiques a base de fluoxetine
KR19990077172A (ko) β-락탐 항생물질 함유 정제 및 그의 제조 방법
MXPA00002290A (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient